COPARK - Prospective Follow-Up of Population with Parkinson's Disease - COPARK Cohort

Head :
Rascol Olivier, INSERM U 825 ET LABORATOIRE PHARMACOLOGIE CLINIQUE DU CHU DE TOULOUSE INSERM

Last update : 07/07/2015 | Version : 2 | ID : 60119

print
Print
xml
XML

Export to XML

Please choose the format :

pdf
PDF
xml
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection

Which version do you want to export ?

send
Send
General
Identification
Detailed name Prospective Follow-Up of Population with Parkinson's Disease - COPARK Cohort
Sign or acronym COPARK
CNIL registration number, number and date of CPP agreement, AFSSAPS (French Health Products Safety Agency) authorisation Accord CNIL
General Aspects
Medical area Neurology
Health determinants Genetic
Keywords Parkinson's symptoms, activities, daily life, Health episodes, quality of life, treatment, mortality
Scientific investigator(s) (Contact)
Name of the director Rascol
Surname Olivier
Address 31000 TOULOUSE
Email rascol@cict.fr
Unit INSERM U 825 ET LABORATOIRE PHARMACOLOGIE CLINIQUE DU CHU DE TOULOUSE INSERM
Organization CHU DE
Collaborations
Participation in projects, networks and consortia Yes
Funding
Funding status Mixed
Details START UP LN PHARMA , ASSOCIATION DE MALADES, INDUSTRIES, INSERM, CHU DE TOULOUSE
Governance of the database
Sponsor(s) or organisation(s) responsible LN PHARMA
Organisation status Private
Additional contact
Main features
Type of database
Type of database Study databases
Study databases (details) Cohort study
Database recruitment is carried out by an intermediary A selection of health institutions and services
Database recruitment is carried out as part of an interventional study No
Additional information regarding sample selection. Inclusion method: Prospective Other bodies active in creating this cohort: CHU, CHG, INDEPENDENT PHYSICIANS Closing date for inclusion: 01/01/2009
Database objective
Main objective General objective: The objective of this multi-disciplinary project (neurology, pharmacology, epidemiology etc.) is to prospectively gather data in a population of outpatients with Parkinson's disease identified through a regional network of hospital neurologists and independent physicians, concerning the onset and progression of motor signs (tremor, akinesia, rigidity, motor complications, freezing, falls, dysarthria ...) and non-motor signs (pain, anxiety and depressive symptoms, autonomic dysfunction, sleep disorders, dementia, apathy, fatigue ...) of PD using validated scales. We will also gather data on quality of life, treatment (care sought and consumption of medication), morbidity and mortality within the same population. Secondary objective: To develop a biobank in the second phase based on phenotypic and pharmacological characterisations outlined in the COPARK population
Inclusion criteria Parkinson's patients with idiopathic Parkinson's disease (UKPDBB criteria) Over 18 years of age, non-institutionalised, with no atypical Parkinsonian syndrome, having never undergone neurosurgery, with no cognitive impairment (MMSE <24), with no serious life-threatening pathology, who have given signed informed consent.
Population type
Age Elderly (65 to 79 years)
Great age (80 years and more)
Population covered Sick population
Gender Male
Woman
Geography area Regional
French regions covered by the database Aquitaine Limousin Poitou-Charentes
Languedoc-Roussillon Midi-Pyrénées
Nord - Pas-de-Calais Picardie
Pays de la Loire
Detail of the geography area 4 REGIONS THROUGHOUT FRANCE (MIDI-PYRENEES, AQUITAINE, PAYS DE LOIRE, NORD PAS DE CALAIS)
Data collection
Dates
Date of first collection (YYYY or MM/YYYY) 12/2006
Date of last collection (YYYY or MM/YYYY) 01/2013
Size of the database
Size of the database (number of individuals) < 500 individuals
Details of the number of individuals 467
Data
Database activity Current data collection
Type of data collected Clinical data
Declarative data
Clinical data (detail) Direct physical measures
Medical registration
Declarative data (detail) Paper self-questionnaire
Presence of a biobank No
Health parameters studied Health event/morbidity
Health event/mortality
Procedures
Data collection method Self-administered questionnaire: Entry from a paper questionnaire (Manual input) with double data entry Interview: Entry from paper questionnaire (manual input) with double data entry Clinical Examinations: Handwritten (Manual input) and double data entry
Participant monitoring Yes
Details on monitoring of participants Follow-up duration: 5 years
Links to administrative sources No
Promotion and access
Promotion
Link to the document http://www.ncbi.nlm.nih.gov/pubmed/?term=%28copark+AND+Rascol+O[Author]%29+OR+24839938[uid]
Description List of publications in Pubmed
Access
Terms of data access (charter for data provision, format of data, availability delay) Data may be used by academic teams Data access for research members and non-members under contract approved by the cohort Scientific Committee and according to the terms governing the charter between different partners Data may be used by industrial teams Data access for research members and non-members under contract that are approved by the cohort Scientific Committee and according to the terms governing the charter between different partners
Access to aggregated data Access on specific project only
Access to individual data Access on specific project only

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05